Second Sight Medical Products Inc.

2.33+0.0600+2.64%Vol 135.22K1Y Perf -56.84%
Jun 24th, 2022 16:00 DELAYED
BID2.28 ASK2.35
Open2.31 Previous Close2.27
Pre-Market- After-Market2.34
 - -  0.01 0.43%
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
415.02 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★★★     61.92
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★+     56.38
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
27.93 
Earnings Rating
Neutral
Market Cap91.82M 
Earnings Date
27th Jun 2022
Alpha0.02 Standard Deviation0.54
Beta2.81 

Today's Price Range

2.252.35

52W Range

1.145.40

5 Year PE Ratio Range

-1.70-0.3000

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
9.91%
1 Month
30.90%
3 Months
58.50%
6 Months
20.73%
1 Year
-56.84%
3 Years
-63.93%
5 Years
-75.53%
10 Years
-

TickerPriceChg.Chg.%
EYES2.330.06002.64
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
25.00
25.20
0.00
0.00
-
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
75.10
-3 915.30
-3 864.60
-973.20
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-50.53
-30.37
Earnings HistoryEstimateReportedSurprise %
Q02 2020--0.15-
Q04 2019-0.49-0.474.08
Q03 2019-0.48-0.480.00
Q02 2019-0.48-0.56-16.67
Q01 2019-0.48-0.80-66.67
Q04 2018-0.88-0.880.00
Q03 2018-1.12-0.9614.29
Q02 2018-0.14-0.1214.29
Earnings Per EndEstimateRevision %Trend
9/2020 QR-0.410.00-
12/2020 QR-0.420.00-
12/2020 FY-1.640.00-
12/2021 FY-1.390.00-
Next Report Date27th Jun 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume135.22K
Shares Outstanding39.41K
Shares Float29.48M
Trades Count1.00K
Dollar Volume312.67K
Avg. Volume292.81K
Avg. Weekly Volume200.39K
Avg. Monthly Volume331.96K
Avg. Quarterly Volume346.06K

Second Sight Medical Products Inc. (NASDAQ: EYES) stock closed at 2.33 per share at the end of the most recent trading day (a 2.64% change compared to the prior day closing price) with a volume of 135.22K shares and market capitalization of 91.82M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 112 people. Second Sight Medical Products Inc. CEO is Matthew J. Pfeffer.

The one-year performance of Second Sight Medical Products Inc. stock is -56.84%, while year-to-date (YTD) performance is 42.94%. EYES stock has a five-year performance of -75.53%. Its 52-week range is between 1.14 and 5.3999, which gives EYES stock a 52-week price range ratio of 27.93%

Second Sight Medical Products Inc. currently has a PE ratio of -10.10, a price-to-book (PB) ratio of 1.32, a price-to-sale (PS) ratio of 101.87, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -17.43%, a ROC of -18.47% and a ROE of -19.28%. The company’s profit margin is -%, its EBITDA margin is -3 864.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Second Sight Medical Products Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Second Sight Medical Products Inc.’s next earnings report date is 27th Jun 2022.

The consensus rating of Wall Street analysts for Second Sight Medical Products Inc. is (0), with a target price of $12, which is +415.02% compared to the current price. The earnings rating for Second Sight Medical Products Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Second Sight Medical Products Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Second Sight Medical Products Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 42.76, ATR14 : 0.16, CCI20 : 28.17, Chaikin Money Flow : 0.10, MACD : 0.10, Money Flow Index : 58.17, ROC : -3.32, RSI : 59.98, STOCH (14,3) : 47.14, STOCH RSI : 1.00, UO : 46.80, Williams %R : -52.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Second Sight Medical Products Inc. in the last 12-months were: Gregg Williams (Buy at a value of $455 946)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

Second Sight Medical Products Inc.

Second Sight Medical Products Inc develops, manufactures and markets implantable prosthetic devices, to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, France and Germany, of which key revenue is derived from the United States.

CEO: Matthew J. Pfeffer

Telephone: +1 818 833-5000

Address: 12744 San Fernando Road, Sylmar 91342, CA, US

Number of employees: 112

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

54%46%

News

Stocktwits